Greater frequency of subcortical lesions in severely demented patients with early onset Alzheimer's disease

Alzheimer's and Dementia

Volumn 3, Issue 1, 2007, Pages 54-57

  Geppert, Anita Malgorzata ^a   Wroblewska, Katarzyna Anna ^a   Przedpelska Ober, Elzbieta Maria ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Alzheimer's disease; CT; MRI; Subcortical lesions

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX LESION; BRAIN DAMAGE; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMENTIA; DISEASE COURSE; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; NERVE CELL LESION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 33846136734     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2006.10.007     Document Type: Article

References (22)

1. Jellinger K.A., and Attems J. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study. Acta Neuropathol 105 (2003) 14-17
2. Kalaria R.N., and Ballard D. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 13 Suppl 3 (1999) 115-123
3. De la Torre J.C., and Stefano G.B. Evidence that Alzheimer′s disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res Rev 34 (2000) 119-136
4. Farkas E., and Luiten P.G. Cerebral microvascular pathology in aging and Alzheimer's disease. Prog Neurobiol 64 (2001) 575-611
5. Esiri M.M., Nagy Z., Smith M.Z., Barnetson L., and Smith A.D. Cerebrovascular disease and threshold for dementia in early stages of Alzheimer's disease. Lancet 364 (1999) 919-920
6. Sparks D.L., Scheff S.W., Liu H., Landers T.M., Coyne C.M., and Hunsaker J.C. Increased incidence of neurofibrillary tangles in non-demented individuals with hypertension. J Neurol Sci 131 (1995) 162-169
7. Skoog I., Lernfelt B., Landahl S., Palmertz B., Andreasson L.A., Nilsson L., et al. 15-year longitudinal study of blood pressure and dementia. Lancet 347 (1996) 1141-1145
8. Ott A., Breteler M.M., de Bruyne M.C., van Harskamp F., Grobbee D.E., and Hofman A. Atrial fibrillation and dementia in a population-based study: the Rotterdam Study. Stroke 28 (1997) 316-321
9. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., O'Brien P.C., et al. Risk of dementia among persons with diabetes mellitus: a population-based study. Am J Epidemiol 145 (1997) 301-308
10. De la Torre J.C. Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease?. Ann N Y Acad Sci 903 (2000) 424-436
11. Fazekas F., Schmidt R., Kleinert R., Kapeller P., Roob G., and Flooh E. The spectrum of age-associated brain abnormalities: their measurement and histopathological correlates. J Neural Transm 53 Suppl (1998) 31-39
12. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
13. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., and Zimmerman R.A. MR signal abnormalities at 1.5 T in Alzheimer′s dementia and normal aging. Am J Roentgenol 149 (1987) 351-356
14. Wahlund L.O., Barkhof F., Fazekas F., Bronge L., Augustin M., Sjogren M., et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 32 (2001) 1318-1322
15. Lee J.H., Olichney J.M., Hansen L.A., Hofstetter C.R., and Thal L.J. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol 57 (2000) 1474-1479
16. Guttmann C.R., Jolesz F.A., Kikinis R., Killiany R.J., Moss M.B., Sandor T., et al. White matter changes with normal aging. Neurology 50 (1998) 972-978
17. Snowdown D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., and Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA 277 (1997) 813-817
18. Frisoni G.B., and Geroldi C. Cerebrovascular disease affects noncognitive symptoms in Alzheimer disease. Arch Neurol 58 (2001) 1939-1940
19. Esiri M.M., Matthews F., Brayne C., Ince P.G., Matthews F.E., Xuereb J.H., et al. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357 (2001) 169-175
20. Saido T.C., Yokota M., Maruyama K., Yamao-Harigaya W., Tani E., Ihara Y., et al. Spatial resolution of the primary beta-amyloidogenic process induced in postischemic hippocampus. J Biol Chem 269 (1994) 15253-15257
21. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
22. Jellinger K.A. Small concomitant cerebrovascular lesions are not important for cognitive decline in severe Alzheimer disease. (letter). Arch Neurol 58 (2001) 520-521